5XKM
Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.3 |
Synchrotron site | ALS |
Beamline | 5.0.3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-09-08 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.97645 |
Spacegroup name | P 1 |
Unit cell lengths | 72.925, 89.768, 90.361 |
Unit cell angles | 107.31, 113.85, 89.84 |
Refinement procedure
Resolution | 84.820 - 2.160 |
R-factor | 0.20452 |
Rwork | 0.202 |
R-free | 0.25635 |
RMSD bond length | 0.005 |
RMSD bond angle | 0.942 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0049) |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 84.820 |
High resolution limit [Å] | 2.160 |
Number of reflections | 100556 |
<I/σ(I)> | 8.5 |
Completeness [%] | 96.8 |
Redundancy | 1.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 293 | 100 mM tris HCl, pH 7.50, 410 mM magnesium chloride hexahydrate, 29.3%w/v PEG 3350 |